You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 8,158,781


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 8,158,781 protect, and when does it expire?

Patent 8,158,781 protects XIFAXAN and is included in one NDA.

This patent has ninety-three patent family members in thirty-seven countries.

Summary for Patent: 8,158,781
Title:Polymorphic forms .alpha., .beta. and .gamma. of rifaximin
Abstract: Crystalline polymorphous forms of rifaximin (INN) antibiotic named rifaximin .alpha. and rifaximin .beta., and a poorly crystalline form named rifaximin .gamma., useful in the production of medicinal preparations containing rifaximin for oral and topical use and obtained by means of a crystallization carried out by hot-dissolving the raw rifaximin in ethyl alcohol and by causing the crystallization of the product by addition of water at a determinate temperature and for a determinate period of time, followed by a drying carried out under controlled conditions until reaching a settled water content in the end product, are the object of the invention.
Inventor(s): Viscomi; Giuseppe Claudio (Bologna, IT), Campana; Manuela (Bologna, IT), Braga; Dario (Bologna, IT), Confortini; Donatella (Bologna, IT), Cannata; Vincenzo (Bologna, IT), Righi; Paolo (Bologna, IT), Rosini; Goffredo (Bologna, IT)
Assignee: Alfa Wassermann, S.p.A. (Bologna, IT)
Application Number:13/041,332
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 8,158,781
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 8,158,781: A Comprehensive Guide

Introduction

When delving into the world of patents, understanding the scope and claims of a particular patent is crucial for inventors, researchers, and business professionals. This article will provide a detailed analysis of the scope and claims of United States Patent 8,158,781, along with an overview of the patent landscape surrounding this invention.

Understanding Patent Scope and Claims

Before diving into the specifics of US Patent 8,158,781, it is essential to grasp the concepts of patent scope and claims.

Patent Scope

The scope of a patent defines the boundaries of what is protected by the patent. It is a critical aspect in determining the patent's validity and enforceability. Metrics such as independent claim length and independent claim count can be used to measure patent scope, as these metrics often correlate with the breadth and clarity of the patent claims[3].

Patent Claims

Patent claims are the legal definitions of what the inventor considers to be their invention. They are the most important part of a patent application and define the scope of protection. Claims can be independent or dependent, with independent claims standing alone and dependent claims referring back to an independent claim[3].

United States Patent 8,158,781 Overview

To analyze the scope and claims of US Patent 8,158,781, we need to identify the key elements of the patent.

Patent Title and Abstract

The title and abstract provide a brief overview of the invention. While the specific details of US Patent 8,158,781 are not provided in the sources, typically, the title would indicate the main subject matter, and the abstract would summarize the invention's purpose and key features.

Background of the Invention

Understanding the background of the invention helps in contextualizing the scope and claims. This section usually explains the existing problems and how the current invention addresses them.

Summary of the Invention

The summary section outlines the main aspects of the invention, including its components, functionality, and any unique features.

Analyzing the Claims

Independent Claims

Independent claims define the core of the invention and are crucial for determining the patent's scope. These claims should be broad enough to cover the invention but not so broad that they become invalid.

Dependent Claims

Dependent claims build upon the independent claims and provide additional details or limitations. They help in narrowing down the scope and ensuring that the patent is more specific and defensible.

Patent Landscape Analysis

Prior Art and Related Patents

To understand the patent landscape, it is essential to search for prior art and related patents. Tools like the USPTO's Patent Public Search, Global Dossier, and databases from other international intellectual property offices can be used to identify similar inventions and ensure that the patent in question does not infringe on existing patents[1].

International Patent Offices

Searching international patent databases such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO) helps in identifying global patent families and potential conflicts[1].

Citation Data

Using tools like the Common Citation Document (CCD), which consolidates citation data from multiple offices, can help in understanding how different patent offices have treated similar inventions. This can provide insights into the validity and scope of the patent claims[1].

Impact of Patent Examination Process

The patent examination process can significantly affect the scope and claims of a patent. Research has shown that the examination process tends to narrow the scope of patent claims, both in terms of claim length and claim count. This narrowing is more pronounced when the examination duration is longer[3].

Practical Steps for Analyzing Patent Scope and Claims

Conducting a Preliminary Search

Use resources like the USPTO's Patent Public Search and other international databases to identify prior art and related patents. This step helps in understanding the existing patent landscape and ensuring that the patent in question is novel and non-obvious[1].

Reviewing Patent Claims

Carefully review the independent and dependent claims to understand the scope of protection. Analyze the claim language for clarity, breadth, and specificity.

Consulting Expert Resources

Utilize resources such as Patent and Trademark Resource Centers (PTRCs) and the USPTO Public Search Facility for expert assistance in patent search techniques and analysis[1].

Case Study: Analyzing a Hypothetical Patent

Let's consider a hypothetical patent similar to US Patent 8,158,781, focusing on a specific invention like polymorphic forms of a pharmaceutical compound.

Identifying Key Claims

Identify the independent claims that define the core of the invention. For example, if the patent is about polymorphic forms of rifaximin, the independent claims might describe the specific crystalline forms (e.g., rifaximin α, β, and γ) and their unique properties[5].

Analyzing Dependent Claims

Review the dependent claims to see how they narrow down the scope. These claims might specify particular methods of preparation, uses, or characteristics of the polymorphic forms.

Evaluating Prior Art

Search for prior art using global databases to ensure that the claimed polymorphic forms are novel and non-obvious. This involves checking for similar patents and publications that might affect the validity of the claims.

Key Takeaways

  • Understand Patent Scope and Claims: The scope defines the boundaries of protection, while claims are the legal definitions of the invention.
  • Conduct Thorough Searches: Use USPTO and international databases to identify prior art and related patents.
  • Analyze Claim Language: Review independent and dependent claims for clarity, breadth, and specificity.
  • Consult Expert Resources: Utilize PTRCs and the USPTO Public Search Facility for expert assistance.
  • Consider the Examination Process: The examination process can narrow the scope of patent claims, affecting their validity and enforceability.

FAQs

Q: How do I determine the scope of a patent?

A: The scope of a patent is determined by analyzing the independent and dependent claims. Metrics such as independent claim length and claim count can also provide insights into the breadth and clarity of the patent.

Q: What are the differences between independent and dependent claims?

A: Independent claims stand alone and define the core of the invention, while dependent claims refer back to an independent claim and provide additional details or limitations.

Q: How can I search for prior art related to a patent?

A: Use tools like the USPTO's Patent Public Search, Global Dossier, and international patent databases such as those provided by the EPO, JPO, and WIPO.

Q: What is the Common Citation Document (CCD), and how is it useful?

A: The CCD consolidates citation data from multiple offices, helping to visualize how different offices have treated similar inventions and providing insights into the validity and scope of patent claims.

Q: How does the patent examination process affect the scope of patent claims?

A: The examination process tends to narrow the scope of patent claims, both in terms of claim length and claim count, with more significant changes occurring when the examination duration is longer.

Sources

  1. USPTO: Search for patents - USPTO. Retrieved from https://www.uspto.gov/patents/search
  2. Unified Patents Portal: US-8835452-B2 - Unified Patents Portal. Retrieved from https://portal.unifiedpatents.com/patents/patent/US-8835452-B2
  3. SSRN: Patent Claims and Patent Scope - Search eLibrary :: SSRN. Retrieved from https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2844964
  4. ClinicalTrials.gov: TITLE PAGE CLINICAL STUDY PROTOCOL A randomized ... Retrieved from https://cdn.clinicaltrials.gov/large-docs/42/NCT02920242/Prot_000.pdf
  5. PubChem: Polymorphic forms α, β and γ of rifaximin - Patent US-7902206-B2 ... Retrieved from https://pubchem.ncbi.nlm.nih.gov/patent/US7902206

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 8,158,781

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Salix Pharms XIFAXAN rifaximin TABLET;ORAL 021361-001 May 25, 2004 RX Yes Yes 8,158,781 ⤷  Subscribe Y ⤷  Subscribe
Salix Pharms XIFAXAN rifaximin TABLET;ORAL 021361-002 Mar 24, 2010 RX Yes Yes 8,158,781 ⤷  Subscribe Y ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 8,158,781

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
ItalyMI2003A2144Nov 07, 2003

International Family Members for US Patent 8,158,781

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Argentina 043547 ⤷  Subscribe
Argentina 081991 ⤷  Subscribe
Argentina 081992 ⤷  Subscribe
Austria 421965 ⤷  Subscribe
Austria 421966 ⤷  Subscribe
Austria E361927 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.